A PHASE 2A, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PTC518 IN SUBJECTS WITH HUNTINGTON'S DISEASE
Research Grant
Awarded By
PTC Therapeutics, Inc
Start Date
January 19, 2022
End Date
May 31, 2024
Awarded By
PTC Therapeutics, Inc
Start Date
January 19, 2022
End Date
May 31, 2024